查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1944464

全球临床前影像市场：产业分析、市场规模、份额及预测（按产品类型、模式、应用、最终用户、国家和地区划分）（2025-2032 年）

Preclinical Imaging Market, By Product Type, By Modality, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 348 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2024 年，临床前影像市场规模将达到 9.9598 亿美元，从 2025 年到 2032 年，复合年增长率将达到 5.54%。

临床前影像市场涵盖用于在人体试验前，利用活体动物模型研究疾病和药物疗效的设备、造影剂和软体。这些工具能够对肿瘤、器官和生物活性进行重复、非侵入性的长期追踪，因此对早期药物发现至关重要，有助于快速、准确地做出决策。常用的影像技术包括用于详细观察解剖结构的微型CT和微型MRI，用于功能和分子讯号分析的PET和SPECT，以及用于使用萤光和生物发光探针进行快速筛检的光学成像。许多实验室正在结合多种技术来提高研究品质。市场需求主要来自肿瘤学、神经病学和感染疾病研究等领域，以及生物製药和先进治疗方法的发展，这些都需要更完善的体内作用机制和生物分布分析。

对于製药公司、合约研究机构 (CRO) 和研究机构等买家而言，他们主要关注事项通常是影像品质、灵敏度、工作流程速度、定量和报告软体、与探针和示踪剂的兼容性、服务支援以及系统运作整个生命週期的总成本。这个市场至关重要，因为良好的临床前影像能够降低早期研发阶段的不确定性，并有助于避免后期研发过程中代价高昂的失败。

临床前影像市场动态

政府大力资助的生物医学研究和大规模的临床试验计画正在增加对临床前影像资料的需求。

临床前影像需求的成长主要受生物医学研究经费增加和众多药物研发项目的推动。这些项目在进入成本高昂的临床试验阶段之前，需要可靠的体内证据，尤其是在肿瘤学、神经科学和先进疗法领域，生物分布和反应监测至关重要。根据国家科学基金会(NSF) 预测，2022 年美国研发总支出将达到约 8,920 亿美元，涵盖实验室营运、合约研究机构 (CRO) 营运和设备采购等研发活动。在医疗卫生领域，美国国立卫生研究院 (NIH) 2023 财政年度的预算授权约为 475 亿美元，2024 财政年度约为 480 亿美元，为大量的临床前研究提供了支持。这些研究通常利用小动物影像进行时间序列分析。临床开发平臺的规模也显示临床前影像需求持续存在。根据美国国家医学图书馆 (NLM) 的 ClinicalTrials.gov 网站数据，2024-2025 年註册的研究项目超过 50 万项，显示该领域研发管线十分庞大。许多专案在推进之前都需要藉助成像技术来概念验证、标靶结合情况并收集安全性资料。这些公开数据显示了市场上的驱动因素：稳定的资金筹措和持续的研发管线活动，使得市场对成像系统、探针和软体的需求持续增长，这些产品能够提供可重复的结果、缩短研究时间并明确判断是否继续进行。

临床前影像市场：細項分析

临床前影像的需求与药物开发平臺的运作和公共研究经费规模密切相关。管线越活跃，需要可测量的体内结果的动物研究就越多。临床试验註册数量是衡量管线规模的便捷方法。根据美国国家医学图书馆的ClinicalTrials.gov资料库，2024年至2025年间註册的研究超过50万项，显示全球药物研发活动十分活跃，而这些研究通常需要在推进后续研究之前获得可靠的临床前资料包。研究层面的经费也支持类似的趋势。根据美国国立卫生研究院（NIH）的数据，NIH 2023财年的预算约为475亿美元，2024财年约为480亿美元，这为肿瘤学、神经病学和感染疾病研究提供了广泛的支持。这些领域经常利用小动物影像进行纵向追踪和治疗反应评估。欧洲也拥有广泛的研发实力。根据欧盟统计局的数据，到 2022-2023 年，欧盟国内研发总支出将维持在 GDP 的 2% 以上，这将支持大学和研究机构对设备的持续需求。

研究技术需求也会影响采购决策。联合影像工作流程的日益普及，尤其是那些需要同时进行结构细节分析、功能分析和分子分析的工作流程，正在推动对分析软体的需求。基于示踪剂的研究依赖核医学能力和同位素供应，这使得临床前PET/SPECT活动与广泛的核医学基础设施相连。预计到2020年代初期，各成员国的核医学能力将扩展，核能（IAEA）报告称，成像系统及相关基础设施的安装数量正在增长，这有助于构建分子成像工作流程所需的生态系统。同时，研究项目对一致性和文件记录的要求不断提高，推动了对能够实现可重复扫描、高运转率和标准化报告的系统的需求。在CRO（合约调查计画）类型的环境中，这一点尤其重要，因为在这些环境中，研究的吞吐量和数据可比性至关重要。

临床前影像市场—区域分析

临床前影像活动通常在生物医学研发经费充裕、拥有大规模大学和医院研究网络以及强大的药物开发平臺的地区最为活跃。这保证了对成像系统、探针和分析软体的稳定需求。北美凭藉其庞大且稳定的公共研究预算，仍是一个重要的市场。根据美国国立卫生研究院 (NIH) 的数据，NIH 在 2023 财年的预算约为 475 亿美元，在 2024 财年约为 480 亿美元，用于支持肿瘤学、神经科学和感染疾病领域众多以成像为核心的研究项目。欧洲的研究活动也保持强劲势头。根据欧盟统计局 (Eurostat) 的数据，预计 2022-2023 财年欧盟研发总支出将维持在 GDP 的 2% 以上，学术和政府研究机构将继续购置设备併升级设施。研发管线的规模也是持续需求的指标之一。根据 ClinicalTrials.gov（美国国家医学图书馆）的数据，预计 2024-2025 年将有超过 500,000 项研究註册，这表明存在大规模的开发平臺，该管线依赖于临床前数据和转化生物标誌物研究。

美国临床前影像市场—国家分析

美国是全球最大的单一市场，这得益于其雄厚的生物医学研究经费基础、许多活跃的研究机构，以及转化研究与製药、生物技术和受託研究机构（CRO）活动的紧密结合。其中，公共资金是最直接的驱动因素。根据美国国立卫生研究院（NIH）的数据，2024财年的年度预算授权约为480亿美元，这将支撑对小型动物影像平台及相关耗材的持续需求。更广泛的研究环境也至关重要。根据国家科学基金会（NSF）的数据，2022年美国研发总支出将达到约8,920亿美元，显示高阶设备和专业工作流程的需求强劲。药物研发活动也带来了额外的需求。根据ClinicalTrials.gov（美国国家医学图书馆）的数据，2024年至2025年间将有超过50万项研究註册，这与临床试验前对基于影像的概念验证、生物分布研究和反应监测的持续需求相吻合。

目录

第一章 临床前影像市场概述

  • 分析范围
  • 市场估算期

第二章执行摘要

  • 市场区隔
  • 竞争考察

第三章 临床前影像的关键市场趋势

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 未来市场趋势

4. 临床前影像市场：产业分析

  • PEST分析
  • 波特五力分析
  • 市场成长展望：概览
  • 管理体制分析

第五章 临床前影像市场：地缘政治紧张局势加剧的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：临床前影像市场概况

  • 临床前影像市场份额分析（2024 年）
  • 主要製造商的细分数据
    • 对现有公司的分析
    • 新兴企业分析

7. 按产品类型分類的临床前影像市场

  • 概述
    • 细分市场占有率分析：依产品类型
    • 影像系统
    • 试剂/探针/造影
    • 软体和服务

8. 依影像方式分類的临床前影像市场

  • 概述
    • 细分市场占有率分析：依治疗方式
    • 光学成像
    • MRI
    • CT
    • PET
    • SPECT
    • 超音波
    • 光声成像

9. 按应用分類的临床前影像市场

  • 概述
    • 细分市场占有率分析：按应用
    • 瘤
    • 神经系统疾病
    • 心臟病
    • 感染疾病
    • 其他的

10. 按最终用户分類的临床前影像市场

  • 概述
    • 细分市场占有率分析：依最终用户划分
    • 製药和生物技术公司
    • CRO（委外研发机构）
    • 学术和研究机构
    • 其他的

11. 按地区分類的临床前影像市场

  • 介绍
  • 北美洲
    • 概述
    • 北美主要製造商
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲主要製造商
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 其他的
  • 亚太地区
    • 概述
    • 亚太地区主要製造商
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 其他的
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他的
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲的主要製造商
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他的

第十二章 主要供应商分析－临床前影像产业

  • 竞争对手仪錶板
    • 竞争基准
    • 竞争定位
  • 公司简介
    • Aspect Imaging Ltd.
    • BIONANO GENOMICS, INC.
    • Biospace Lab SA
    • Bruker Corporation
    • Canon Medical Systems Corporation
    • CubiX Imaging, Inc.
    • FUJIFILM VisualSonics Inc.
    • GE HealthCare Technologies Inc.
    • Mediso Ltd.
    • MILabs BV
    • MinFound Medical Systems Co., Ltd.
    • MR Solutions Group Ltd.
    • Nanoscan Imaging Ltd.
    • PerkinElmer Inc.
    • Philips International BV
    • Revvity, Inc.
    • Siemens Healthineers AG
    • Sofie Biosciences, Inc.
    • TriFoil Imaging, Inc.
    • Trifoil Imaging, Inc.
    • Others

第十三章：分析师的全方位展望

简介目录
Product Code: ANV6068

Preclinical Imaging Market size was valued at US$ 995.98 Million in 2024, expanding at a CAGR of 5.54% from 2025 to 2032.

The preclinical imaging market includes the equipment, imaging agents, and software used to study diseases and drug effects in live animal models before human trials. These tools are important in early research because they allow repeated, non-invasive tracking of tumors, organs, or biological activity over time, which supports faster and more confident decisions in drug discovery. Common imaging options include micro-CT and micro-MRI for detailed anatomy, PET and SPECT for functional or molecular signals, and optical imaging for quick screening using fluorescent or bioluminescent probes, with many labs combining more than one method to improve study quality. Demand is linked to areas like oncology, neurology, and infectious disease research, plus the growth of biologics and advanced therapies that need better in vivo proof of mechanism and biodistribution.

For buyers such as pharma companies, CROs, and research institutes, the main focus is usually on image quality, sensitivity, workflow speed, software for quantification and reporting, compatibility with probes and tracers, service support, and the overall cost of running the system over its lifetime. This market matters because better preclinical imaging can reduce uncertainty earlier in development and help avoid expensive failures later in the pipeline.

Preclinical Imaging Market- Market Dynamics

Strong government-funded biomedical research and a large clinical pipeline are increasing the need for preclinical imaging data

Preclinical imaging demand is rising because more biomedical research funding and a large flow of drug programs require solid in vivo evidence before expensive clinical steps, especially for oncology, neuroscience, and advanced therapies, where biodistribution and response monitoring are critical. According to the U.S. National Science Foundation (NSF), total U.S. research and development spending reached about USD 892 billion in 2022, showing the overall scale of R&D activity that supports labs, CRO work, and equipment purchasing. In health-focused research, according to the National Institutes of Health (NIH), NIH budget authority was around USD 47.5 billion in FY2023 and about USD 48.0 billion in FY2024, which supports a large number of preclinical studies that often rely on small-animal imaging for longitudinal readouts. The size of the clinical development funnel also signals ongoing preclinical demand; According to ClinicalTrials.gov (U.S. National Library of Medicine), the registry listed more than 500,000 studies during 2024-2025, indicating a broad pipeline where many programs need imaging-backed proof-of-concept, target engagement, and safety support before moving forward. These public indicators point to a practical buying driver in the market: stable funding and steady pipeline activity create ongoing need for imaging systems, probes, and software that can deliver repeatable results, faster study timelines, and clearer go/no-go decisions.

Preclinical Imaging Market- Segmentation Analysis:

Preclinical imaging demand is closely tied to how busy the drug development pipeline is and how much public research funding is available, because higher activity creates more animal studies that need measurable in vivo results. A simple way to see the pipeline scale is through trial registration volume; according to ClinicalTrials.gov (U.S. National Library of Medicine), the database listed more than 500,000 studies during 2024-2025, which signals steady global development work that usually requires stronger preclinical packages before moving forward. Funding also supports the same trend at the research level; according to the National Institutes of Health (NIH), NIH budget authority was about USD 47.5 billion in FY2023 and around USD 48.0 billion in FY2024, keeping a large base of oncology, neurology, and infectious disease research active, where small-animal imaging is often used for longitudinal tracking and treatment response measurement. In Europe, broad R&D intensity has also been maintained; according to Eurostat, EU gross domestic expenditure on R&D stayed above 2% of GDP in 2022-2023, which supports continued equipment demand from universities and research institutes.

Technology needs inside studies also shape buying decisions, especially when a study requires both structural detail and functional or molecular readouts, which pushes more combined imaging workflows and more demand for analysis software. Tracer-based work depends on nuclear medicine capacity and isotope supply, which connects preclinical PET/SPECT activity with wider nuclear medicine infrastructure. According to the International Atomic Energy Agency (IAEA), nuclear medicine capability expanded across member states through the early 2020s, supported by reported growth in installed imaging systems and related infrastructure, which helps build the ecosystem needed for molecular imaging workflows. Alongside this, stronger expectations around consistency and documentation in research programs are increasing demand for systems that can deliver repeatable scans, higher uptime, and standardized reporting, especially in CRO-style environments where throughput and data comparability across studies matter.

Preclinical Imaging Market- Geographical Insights

Preclinical imaging activity is usually strongest in regions with high biomedical R&D spending, large university and hospital research networks, and steady drug development pipelines, which keeps demand consistent for imaging systems, probes, and analysis software. North America remains important because public research budgets are large and stable; according to the National Institutes of Health (NIH), NIH budget authority was about USD 47.5 billion in FY2023 and about USD 48.0 billion in FY2024, supporting many imaging-heavy programs in cancer, neuroscience, and infectious disease. Europe also shows sustained research intensity; according to Eurostat, EU gross domestic expenditure on R&D stayed above 2% of GDP in 2022-2023, which supports continued equipment purchasing and facility upgrades in academic and government research institutes. Pipeline scale is another indicator of ongoing demand; according to ClinicalTrials.gov (U.S. National Library of Medicine), the registry listed more than 500,000 studies during 2024-2025, which signals a large development funnel that depends on preclinical evidence and translational biomarker work.

United States Preclinical Imaging Market- Country Insights

The United States is the strongest single-country market because the funding base for biomedical research is large, the number of active research organizations is high, and translational work is closely linked to pharma, biotech, and CRO activity. The most direct driver is public funding; according to the National Institutes of Health (NIH), annual budget authority stayed near USD 48 billion in FY2024, which supports continuous demand for small-animal imaging platforms and related consumables. The broader research environment is also large; according to the U.S. National Science Foundation (NSF), total U.S. spending on research and development reached about USD 892 billion in 2022, showing strong capacity for high-end instruments and specialized workflows. Drug development activity adds another demand layer; according to ClinicalTrials.gov (U.S. National Library of Medicine), registered studies exceeded 500,000 during 2024-2025, which aligns with ongoing needs for imaging-based proof-of-concept, biodistribution studies, and response monitoring before clinical commitments.

Preclinical Imaging Market- Competitive Landscape:

The preclinical imaging vendor landscape is usually discussed by modality strengths and workflow integration, because buyers tend to compare resolution, sensitivity, throughput, software quantification, and service support across platforms. Bruker Corporation is commonly referenced for preclinical MRI and micro-CT systems and integrated imaging workflows for research labs. Revvity, Inc. is frequently associated with optical imaging and reagent ecosystems used for fast in vivo screening and longitudinal monitoring. FUJIFILM VisualSonics Inc. is often linked to high-resolution preclinical ultrasound and photoacoustic imaging used in cardiovascular and oncology research. For nuclear imaging workflows, MILabs B.V. and Mediso Ltd. are typically cited for preclinical PET/SPECT systems and multi-modal configurations that support tracer-based studies. Larger imaging groups such as Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., and Canon Medical Systems Corporation are also referenced in the space due to strengths in imaging technology and software that support translational collaborations. Public demand signals explain why competition stays active; according to NIH and according to ClinicalTrials.gov (U.S. National Library of Medicine), the scale of research funding and the large pipeline of studies supports continued investment in higher-throughput systems, standardized analysis tools, and multi-modality imaging setups.

Recent Developments:

In October 2025, The START Center for Cancer Research, an oncology-focused clinical research organization, along with its preclinical division XenoSTART, and Minerva Imaging, a radiopharmaceutical CRO/CDMO specializing in molecular imaging and radionuclide therapy, expanded their long-running partnership to build an integrated platform for radiopharmaceutical drug development by combining clinically annotated patient-derived xenograft (PDX) models with advanced imaging capabilities such as PET/CT, SPECT/CT, and MRI plus GMP manufacturing, aiming to shorten timelines and reduce development risk for oncology radiopharmaceutical programs.

In September 2025, Revvity, Inc., a provider of health science solutions and preclinical imaging tools, launched Living Image(TM) Synergy AI, a multimodal in vivo imaging analysis software platform designed to unify data analysis across optical, microCT, ultrasound, and other modalities; the software adds AI-based automation for tasks such as image segmentation and ROI quantification to reduce manual work, improve throughput, and enhance reproducibility, and it was scheduled to be showcased at the WMIC conference in late September 2025.

In September 2023, Revvity, Inc., a supplier of preclinical imaging systems and workflow solutions, expanded its imaging portfolio with the launch of the next-generation IVIS(R) Spectrum 2 and IVIS SpectrumCT 2 optical imaging systems, the Quantum(TM) GX3 microCT solution, and the global debut of the Vega(R) ultrasound system, targeting higher sensitivity, resolution, and faster throughput for in vivo and ex vivo preclinical research workflows and presenting the systems at the World Molecular Imaging Congress (WMIC) in Prague.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PRECLINICAL IMAGING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Aspect Imaging Ltd.
  • BIONANO GENOMICS, INC.
  • Biospace Lab S.A.
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • CubiX Imaging, Inc.
  • FUJIFILM VisualSonics Inc.
  • GE HealthCare Technologies Inc.
  • Mediso Ltd.
  • MILabs B.V.
  • MinFound Medical Systems Co., Ltd.
  • MR Solutions Group Ltd.
  • Nanoscan Imaging Ltd.
  • PerkinElmer Inc.
  • Philips International B.V.
  • Revvity, Inc.
  • Siemens Healthineers AG
  • Sofie Biosciences, Inc.
  • TriFoil Imaging, Inc.
  • Trifoil Imaging, Inc.
  • Others

GLOBAL PRECLINICAL IMAGING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Imaging Systems
  • Reagents & Probes/Contrast Agents
  • Software & Services

GLOBAL PRECLINICAL IMAGING MARKET, BY MODALITY- MARKET ANALYSIS, 2019 - 2032

  • Optical Imaging
  • MRI
  • CT
  • PET
  • SPECT
  • Ultrasound
  • Photoacoustic Imaging

GLOBAL PRECLINICAL IMAGING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Neurology
  • Cardiology
  • Infectious Diseases
  • Others

GLOBAL PRECLINICAL IMAGING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic & Research Institutes
  • Others

GLOBAL PRECLINICAL IMAGING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Preclinical Imaging Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Preclinical Imaging Market Snippet by Product Type
    • 2.1.2. Preclinical Imaging Market Snippet by Modality
    • 2.1.3. Preclinical Imaging Market Snippet by Application
    • 2.1.4. Preclinical Imaging Market Snippet by End User
    • 2.1.5. Preclinical Imaging Market Snippet by Country
    • 2.1.6. Preclinical Imaging Market Snippet by Region
  • 2.2. Competitive Insights

3. Preclinical Imaging Key Market Trends

  • 3.1. Preclinical Imaging Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Preclinical Imaging Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Preclinical Imaging Market Opportunities
  • 3.4. Preclinical Imaging Market Future Trends

4. Preclinical Imaging Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Preclinical Imaging Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Preclinical Imaging Market Landscape

  • 6.1. Preclinical Imaging Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Preclinical Imaging Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Imaging Systems
    • 7.1.3. Reagents & Probes/Contrast Agents
    • 7.1.4. Software & Services

8. Preclinical Imaging Market - By Modality

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Modality, 2024 & 2032 (%)
    • 8.1.2. Optical Imaging
    • 8.1.3. MRI
    • 8.1.4. CT
    • 8.1.5. PET
    • 8.1.6. SPECT
    • 8.1.7. Ultrasound
    • 8.1.8. Photoacoustic Imaging

9. Preclinical Imaging Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Oncology
    • 9.1.3. Neurology
    • 9.1.4. Cardiology
    • 9.1.5. Infectious Diseases
    • 9.1.6. Others

10. Preclinical Imaging Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Modality, 2024 & 2032 (%)
    • 10.1.2. Pharmaceutical & Biotechnology Companies
    • 10.1.3. Contract Research Organizations (CROs)
    • 10.1.4. Academic & Research Institutes
    • 10.1.5. Others

11. Preclinical Imaging Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Preclinical Imaging Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Preclinical Imaging Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Preclinical Imaging Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Preclinical Imaging Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Preclinical Imaging Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Preclinical Imaging Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Aspect Imaging Ltd.
    • 12.2.2. BIONANO GENOMICS, INC.
    • 12.2.3. Biospace Lab S.A.
    • 12.2.4. Bruker Corporation
    • 12.2.5. Canon Medical Systems Corporation
    • 12.2.6. CubiX Imaging, Inc.
    • 12.2.7. FUJIFILM VisualSonics Inc.
    • 12.2.8. GE HealthCare Technologies Inc.
    • 12.2.9. Mediso Ltd.
    • 12.2.10. MILabs B.V.
    • 12.2.11. MinFound Medical Systems Co., Ltd.
    • 12.2.12. MR Solutions Group Ltd.
    • 12.2.13. Nanoscan Imaging Ltd.
    • 12.2.14. PerkinElmer Inc.
    • 12.2.15. Philips International B.V.
    • 12.2.16. Revvity, Inc.
    • 12.2.17. Siemens Healthineers AG
    • 12.2.18. Sofie Biosciences, Inc.
    • 12.2.19. TriFoil Imaging, Inc.
    • 12.2.20. Trifoil Imaging, Inc.
    • 12.2.21. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us